Combination chemo-immunotherapy with adriamycin in experimental tumor systems.
D000818:Animals; D001500:BCG Vaccine / Q000627:therapeutic use; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004306:Dose-Response Relationship, Immunologic; D004317:Doxorubicin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D007939:Leukemia L1210 / Q000628:therapy; D007978:Levamisole / Q000627:therapeutic use; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009374:Neoplasms, Experimental / Q000628:therapy*; D011425:Propionibacterium acnes / Q000276:immunology
D001500:BCG Vaccine; D001428:Bacterial Vaccines; D007978:Levamisole; D004317:Doxorubicin